Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Net Income towards Common Stockholders: 2012-2025

Historic Net Income towards Common Stockholders for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to $26.5 million.

  • Phibro Animal Health's Net Income towards Common Stockholders rose 280.32% to $26.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.1 million, marking a year-over-year increase of 123.38%. This contributed to the annual value of $43.5 million for FY2025, which is 228.61% up from last year.
  • According to the latest figures from Q3 2025, Phibro Animal Health's Net Income towards Common Stockholders is $26.5 million, which was up 112.71% from $12.5 million recorded in Q2 2025.
  • In the past 5 years, Phibro Animal Health's Net Income towards Common Stockholders ranged from a high of $26.5 million in Q3 2025 and a low of -$8.0 million during Q3 2023.
  • For the 3-year period, Phibro Animal Health's Net Income towards Common Stockholders averaged around $9.3 million, with its median value being $8.6 million (2023).
  • As far as peak fluctuations go, Phibro Animal Health's Net Income towards Common Stockholders tumbled by 307.86% in 2023, and later surged by 280.32% in 2025.
  • Phibro Animal Health's Net Income towards Common Stockholders (Quarterly) stood at $17.5 million in 2021, then tumbled by 58.72% to $7.2 million in 2022, then tumbled by 82.33% to $1.3 million in 2023, then skyrocketed by 150.00% to $3.2 million in 2024, then spiked by 280.32% to $26.5 million in 2025.
  • Its Net Income towards Common Stockholders was $26.5 million in Q3 2025, compared to $12.5 million in Q2 2025 and $20.9 million in Q1 2025.